Fundraising FoxForbion — 2026 Investments
10 investments dated 2026 · listed companies and verified rows first · show all
Mestag is an immunology company developing first-in-class treatments for cancer and inflammatory diseases by leveraging novel understanding of fibroblast biology and tertiary lymphoid structures.
AI & Machine LearningBiotechDigital HealthHealthtechLondon, GB
Michael B. Brenner(Founder)Chris Buckley(Founder)Mark Coles(Founder)inSoumya Raychaudhuri(Founder)David A. Tuveson(Founder)Lindsey Rolfe(Chief Medical Officer)in
Co-investorsGV (Google Ventures)SV Health InvestorsJohnson & Johnson Innovation – JJDCNorthpond VenturesJJDC
Solstice Oncology is a clinical-stage immuno-oncology company developing porustobart, a second-generation engineered CTLA-4 antibody given with anti–PD-1 therapy in the neoadjuvant (pre-surgery) setting to treat early-stage cancers.
BiotechHealthtechBoston, US
David Feltquate(Chief Medical Officer)inMaiken Keson-Brookes(Chief Operating Officer & General Counsel)CAROLINE LOEW(Executive Officer, Director, Promoter)Caroline J. Loew(President & Chief Executive Officer)
BoardANDREW LEVIN(Director)JULIE GRANT(Director)in
Co-investorsRA CapitalCanaan Partners
Altesa BioSciences is a clinical-stage pharmaceutical company developing vapendavir, an orally administered antiviral targeting rhinovirus infections in patients with chronic lung diseases such as COPD and asthma.
BiotechHealthtechCollege Park, US
John Clerici(Executive Officer)inAndrew Drechsler(Executive Officer)Brett Giroir(Executive Officer, Director)
BoardNicholas Williams(Director)Moncef Slaoui(Director)Jon Edwards(Director)in
Co-investorsGRA VentureMedicxiPitangoSanofi Ventures
Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.
AI & Machine LearningBiotech
Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)inMarie De Vulder(Chief Legal Officer Co-founder)inGuy Peeters(Chief Financial Officer Co-founder)inJohn-Paul Gallivan(Head of Development Co-founder)inFabrice Kolb(Head of Immunology Co-founder)inPieter Peeters(Operating & Technology Officer Co-founder)in
Co-investorsFinchley Healthcare VenturesLongwood FundLuma GroupSofinnova VenturesBAM ElevateNovo Holdings+2 more
Modern Systems Talk (MST) publishes content and insights on technology topics including system architecture, cloud computing, automation, AI, cybersecurity, and digital transformation.
Media & Entertainment
Co-investorsAgate Medical Investments LPSCP Vitalife PartnersGV (Google Ventures)Northpond VenturesSV Health Investors
Oncology Ventures is a cancer-focused venture capital fund that invests in healthcare technology startups related to oncology care.
AI & Machine LearningBiotechDigital HealthHealthtech
Ben Freeberg(Founder, Managing Partner)inJay Freeberg(Chief Financial Officer)
Co-investorsSandwich CapitalAlleyCorpCanaan PartnersConcord Health PartnersCVS Health VenturesForesite Capital+5 more
RQ Bio discovers and develops long-acting monoclonal antibodies (LAAbs) targeting seasonal influenza to provide protection against severe viral disease.
BiotechHealthtech
Co-investorsFrazier Life SciencesLifeArc VenturesOxford Science EnterprisesWellington ManagementEQT Life SciencesMonograph Capital Partners+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Memento MedicinesCorsera HealthOMass Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.